{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "6133802",
  "DateCompleted": {
    "Year": "1983",
    "Month": "07",
    "Day": "15"
  },
  "DateRevised": {
    "Year": "2017",
    "Month": "02",
    "Day": "14"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0300-0605",
      "JournalIssue": {
        "Volume": "11",
        "Issue": "2",
        "PubDate": {
          "Year": "1983"
        }
      },
      "Title": "The Journal of international medical research",
      "ISOAbbreviation": "J Int Med Res"
    },
    "ArticleTitle": "Relieving symptoms of upper respiratory allergies and the common cold: azatadine maleate/pseudoephedrine sulfate syrup versus placebo.",
    "Pagination": {
      "StartPage": "101",
      "EndPage": "107",
      "MedlinePgn": "101-7"
    },
    "Abstract": {
      "AbstractText": [
        "A total of 132 patients with symptoms associated with either upper respiratory allergies or the common cold was enrolled in this 5-day study. Azatadine maleate/pseudoephedrine sulfate syrup was compared to placebo using a double-blind design. Evaluation of efficacy was based on results in eighty patients and that of safety in 115. Onset of relief was significantly better (p = 0.03) with azatadine maleate/pseudoephedrine sulfate syrup than with placebo. However this was due mainly to the distribution of patients who indicated 'no relief': ten in the combination group as opposed to sixteen in the placebo group. Over-all evaluation of results indicated that a significantly greater degree of symptomatic relief was achieved with the active test formulation than with placebo on both Days 3 (p = 0.03) and 5 (p = 0.04) of therapy. Somnolence was the most frequently reported side-effect."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Kaminszczik",
        "ForeName": "I",
        "Initials": "I"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Barbon",
        "ForeName": "L",
        "Initials": "L"
      }
    ],
    "PublicationTypeList": [
      "Clinical Trial",
      "Comparative Study",
      "Journal Article",
      "Randomized Controlled Trial"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "J Int Med Res",
    "NlmUniqueID": "0346411",
    "ISSNLinking": "0300-0605"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Drug Combinations"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Histamine H1 Antagonists"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Placebos"
    },
    {
      "RegistryNumber": "2YHB6175DO",
      "NameOfSubstance": "Cyproheptadine"
    },
    {
      "RegistryNumber": "94Z39NID6C",
      "NameOfSubstance": "azatadine"
    },
    {
      "RegistryNumber": "GN83C131XS",
      "NameOfSubstance": "Ephedrine"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adolescent"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Aged"
    },
    {
      "QualifierName": [
        "drug therapy"
      ],
      "DescriptorName": "Common Cold"
    },
    {
      "QualifierName": [
        "adverse effects",
        "analogs & derivatives",
        "therapeutic use"
      ],
      "DescriptorName": "Cyproheptadine"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Double-Blind Method"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Drug Combinations"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Drug Evaluation"
    },
    {
      "QualifierName": [
        "adverse effects",
        "therapeutic use"
      ],
      "DescriptorName": "Ephedrine"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Histamine H1 Antagonists"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Middle Aged"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Placebos"
    },
    {
      "QualifierName": [
        "drug therapy"
      ],
      "DescriptorName": "Respiratory Hypersensitivity"
    }
  ]
}